New insights into how AI will lead to developments in assisted reproductive technology
The 10
th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) has provided exciting insights into likely developments and future possibilities in assisted reproductive technology including artificial intelligence.
Since the first IVF baby was born in 1978, more than eight million babies have been delivered as a result of the assisted reproductive technique.
In that time, there have been amazing advances in technology and treatment protocols to help the one in six couples living with infertility to fulfil their dreams of parenthood. One child in every 20 born today is an IVF baby, and another five per cent of babies around the world are conceived with the help of fertility drugs.
Monday, 10 May 2021, 5:19 pm
SINGAPORE, May 10, 2021 /PRNewswire/ The first births
and on-going well-being of babies born from an advanced
assisted reproduction process called CAPA in-vitro oocyte
maturation, or IVM, has highlighted the potential of the
procedure for millions of women with complex fertility
issues including polycystic ovarian syndrome
(PCOS).
IVM is a technique to obtain oocytes that are
developed in vitro prior to fertilisation with sperm in a
laboratory with an embryo transferred back into a patient s
uterus with the aim of an ongoing pregnancy and live
birth.
A major benefit of IVM is that it requires
minimal hormonal stimulation of the ovaries that is a
SINGAPORE, May 8, 2021 /PRNewswire/ Mounting concerns about access to infertility treatment in low to middle income countries and measures to address the problem have come into sharp focus at the 10th Congress of the Asia Pacific Initiative on Reproduction .
Embryo gene editing in IVF can have potential major impacts on humanity
May 6 2021
A global conference on human fertility has been warned of huge societal and ethical challenges regulating advances in gene editing in assisted reproduction.
Speaking at the 10
th Congress of the Asian Pacific Initiative of Reproduction (ASPIRE), Dr Catherine Racowsky said embryo gene editing was a growing likelihood among latest advances in IVF with potential major impacts on humanity. The international community is working hard to develop regulatory guidelines regarding alterations in human genetics, but big questions remain about how and where they will be applied, she said.